2014
DOI: 10.1016/j.maturitas.2014.06.002
|View full text |Cite
|
Sign up to set email alerts
|

EMAS position statement: Management of uterine fibroids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
61
0
11

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 100 publications
(72 citation statements)
references
References 128 publications
0
61
0
11
Order By: Relevance
“…The bleeding can lead to chronic anemia and severely reduced quality of life. 5 This benign tumor of the muscle layer of the uterus is hormonally dependent, developing after puberty and tending to shrink after menopause. 6,7 The factors that initiate tumorigenesis are not known, but both estrogen and progesterone are important for growth (reviewed by Bulun 8 ).…”
Section: Introductionmentioning
confidence: 99%
“…The bleeding can lead to chronic anemia and severely reduced quality of life. 5 This benign tumor of the muscle layer of the uterus is hormonally dependent, developing after puberty and tending to shrink after menopause. 6,7 The factors that initiate tumorigenesis are not known, but both estrogen and progesterone are important for growth (reviewed by Bulun 8 ).…”
Section: Introductionmentioning
confidence: 99%
“…Of existing alternatives to standard therapies, HIFU appears to be one of the most promising in that its advantages include: (a) noninvasiveness, (b) patient wellbeing due to avoidance of scar formation (c) low risk of immune responses as will be discussed below, (d) accuracy and (e) ease of use, the latter two based on our own clinical experience. HIFU is already widely applied in clinical practice and is used to treat, among other diseases, breast lesions [19], uterine fibroids [20] and prostate cancer [21]. It is also further being developed to treat kidney and liver tumors [22].…”
mentioning
confidence: 99%
“…Данные по этому вопросу мало-численны, однако практически во всех исследовани-ях не установлено достоверного увеличения объема миоматозных узлов на фоне непрерывного комби-нированного режима МГТ. При субмукозном росте миомы матки МГТ увеличивает риск аномальных маточных кровотечений [15].…”
Section: выводыunclassified